Clinical Trial Update: Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating semaglutide in patients undergoing transcatheter aortic valve replacement (TAVR) for aortic stenosis and heart failure. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis
• Heart Failure

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Aortic Stenosis, Heart Failure | Phase 3 | Status: NOT_YET_RECRUITING